@yaireinhorn 1 year ago
2/In @doudna_lab’s vision - the future of #CRISPR #GeneEditing will intersect with other #technologies such as #MachineLearning, cell #Imaging & #Sequencing while #FDA approval for the first $CRSP CRISPR-based medicine will help advance others to later stages of #clinicaltrials. https://t.co/lRcaNmatQv
@xconomy.com 5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com 5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com 5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@techcrunch.com 8 years ago
Innovation in genomics and the future of medtech